Lymphocyte MAP™
Key Features of The Lymphocyte MAP™
Thirteen immunotypes uniquely designed to capture and highlight important immune trends revealed due to the comprehensive number of determinants and biomarkers tested.
T-helper-1 or T-helper-2 Dominance (Immunotypes 6 and 7)
Includes the Cyrex Fluorescence Activated Cell Test (FACT™), a breakthrough proprietary process, is used to classify Th1/Th2 balance, based on the specific clusters of differentiation (CD markers) on the surface membranes of Th1 or Th2 cells, and NOT on the measurement of Th1/Th2-associated cytokine levels in the blood, commonly used by other laboratories.
T-helper-17 Dominance (Immunotype 9)
Includes the Cyrex FACT™ , a proprietary process based on direct measurement of the CD markers on the surface membranes of the cells, and NOT by measuring IL-17 levels in the blood.These industry-changing features result in a more accurate picture of T-helper cell status than currently available on the market.
The most comprehensive immunophenotyping panel offered on the market, creating the broadest picture of immune status.
Key Features of The Lymphocyte MAP™
Thirteen immunotypes uniquely designed to capture and highlight important immune trends revealed due to the comprehensive number of determinants and biomarkers tested.
T-helper-1 or T-helper-2 Dominance (Immunotypes 6 and 7)
Includes the Cyrex Fluorescence Activated Cell Test (FACT™), a breakthrough proprietary process, is used to classify Th1/Th2 balance, based on the specific clusters of differentiation (CD markers) on the surface membranes of Th1 or Th2 cells, and NOT on the measurement of Th1/Th2-associated cytokine levels in the blood, commonly used by other laboratories.
T-helper-17 Dominance (Immunotype 9)
Includes the Cyrex FACT™ , a proprietary process based on direct measurement of the CD markers on the surface membranes of the cells, and NOT by measuring IL-17 levels in the blood.These industry-changing features result in a more accurate picture of T-helper cell status than currently available on the market.
The most comprehensive immunophenotyping panel offered on the market, creating the broadest picture of immune status.
Key Features of The Lymphocyte MAP™
Thirteen immunotypes uniquely designed to capture and highlight important immune trends revealed due to the comprehensive number of determinants and biomarkers tested.
T-helper-1 or T-helper-2 Dominance (Immunotypes 6 and 7)
Includes the Cyrex Fluorescence Activated Cell Test (FACT™), a breakthrough proprietary process, is used to classify Th1/Th2 balance, based on the specific clusters of differentiation (CD markers) on the surface membranes of Th1 or Th2 cells, and NOT on the measurement of Th1/Th2-associated cytokine levels in the blood, commonly used by other laboratories.
T-helper-17 Dominance (Immunotype 9)
Includes the Cyrex FACT™ , a proprietary process based on direct measurement of the CD markers on the surface membranes of the cells, and NOT by measuring IL-17 levels in the blood.These industry-changing features result in a more accurate picture of T-helper cell status than currently available on the market.
The most comprehensive immunophenotyping panel offered on the market, creating the broadest picture of immune status.